Evidence map›Paper›PMID 33271757›Full record

ArticleFoods (Basel, Switzerland)2020

The Biotechnological Potential of

Camelia Filofteia Diguță, George Daniel Nițoi, Florentina Matei, Gabriela Luță, Călina Petruța Cornea

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Functional Profiling ofMicroorganisms · 2025
    Article
  7. Review
  8. Probiotic Potential ofMicroorganisms · 2025
    Article
  9. Article
  10. Comparative genomic analysis of theComputational and structural biotechnology journal · 2025
    Article
  11. Article
  12. Article
  13. Anti-Inflammatory Effects of Novel ProbioticFoods (Basel, Switzerland) · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Foods (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Camelia Filofteia DiguțăFaculty of Biotechnologies, University of Agronomic Sciences and Veterinary Medicine Bucharest, 59 Mărăști Blvd., 011464 Bucharest, Romania.
George Daniel NițoiFaculty of Biotechnologies, University of Agronomic Sciences and Veterinary Medicine Bucharest, 59 Mărăști Blvd., 011464 Bucharest, Romania.
Florentina MateiFaculty of Biotechnologies, University of Agronomic Sciences and Veterinary Medicine Bucharest, 59 Mărăști Blvd., 011464 Bucharest, Romania.
Gabriela LuțăFaculty of Biotechnologies, University of Agronomic Sciences and Veterinary Medicine Bucharest, 59 Mărăști Blvd., 011464 Bucharest, Romania.
Călina Petruța CorneaFaculty of Biotechnologies, University of Agronomic Sciences and Veterinary Medicine Bucharest, 59 Mărăști Blvd., 011464 Bucharest, Romania.
University of Agronomic Sciences and Veterinary Medicine of Bucharest · RO

Funding

Ministry of Education and Research, Romania PN-III-CERC-CO-BG-2016
6 · The paper itself

Abstract

In the past decade, the probiotic market has grown rapidly, both for foods and supplements intended to enhance wellness in healthy individuals. Different lactic acid bacteria (LAB), especially

Indexed as

antimicrobialKombuchalactic acid bacteria (LAB)lyophilizationPediococcus spp.probiotic

Identifiers

PMID33271757
PMCPMC7760545
OpenAlexW3108490499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.